Search

everythinglearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Dutasteride reduces prostate cancer risk by 23% in high-risk men.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Finasteride may reduce prostate tumor cell invasion and spread.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Finasteride reduces prostate cancer risk but may increase aggressive cancer risk slightly.

Finasteride is safe for long-term use in prostate cancer treatment.

Finasteride improves prostate cancer detection in PSA test.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

5-alpha reductase inhibitors may reduce bladder cancer recurrence and improve survival.

Finasteride is effective for treating BPH but not recommended for prostate cancer prevention.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

Early detection and personalized treatment are crucial to prevent Barrett's esophagus from becoming cancer.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.